Zobrazeno 1 - 10
of 46
pro vyhledávání: '"E. H. McLaren"'
Autor:
E. H. McLaren, Anne Pollock
Publikováno v:
Clinical Endocrinology. 49:513-516
OBJECTIVE Non-tumour causes of hyperprolactinaemia, including prolactin-elevating drugs, must be excluded. There is a general view that such drugs are unlikely to raise serum PRL above 3000 mU/l, but the literature is confusing. We report 8 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1accdef3c2f6b6be1ac3dca6749b09bf
https://doi.org/10.1046/j.1365-2265.1998.00569.x
https://doi.org/10.1046/j.1365-2265.1998.00569.x
Publikováno v:
Health bulletin. 57(2)
To examine patterns of acute medical emergency admissions and the effect of reorganisation on their management.Examination of statistics for emergency medical admissions from 1992 to 1997, a period that included a major reorganisation of the emergenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f86014408d74a82a4092a03042e961ac
https://pubmed.ncbi.nlm.nih.gov/12811902
https://pubmed.ncbi.nlm.nih.gov/12811902
Autor:
E H. McLaren, A.D. McMahon, M A. Pollock, Kate Davidson, Karen E. Marshall, Anne Sturrock, C.J.G Kelly
Publikováno v:
BMJ (Clinical research ed.). 323(7318)
OBJECTIVES: To determine whether thyroxine treatment is effective in patients with symptoms of hypothyroidism but with thyroid function tests within the reference range, and to investigate the effect of thyroxine treatment on psychological and physic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bdce53c5c541ded84d6d6d59f25083e
https://pubmed.ncbi.nlm.nih.gov/11668132
https://pubmed.ncbi.nlm.nih.gov/11668132
Publikováno v:
Practical Diabetes International. 9:134-136
The long-term glycaemic control, assessed by the mean of three successive levels of glycosylated haemoglobin (HbA1c) achieved in a special clinic for insulindependent diabetics aged 12–40, was audited in 1984 and 1987. Clinic policy involved a twic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6b48511e4c945516e0fbabae6503f34
https://doi.org/10.1002/pdi.1960090405
https://doi.org/10.1002/pdi.1960090405
Autor:
A, Pollock, E H, McLaren
Publikováno v:
Clinical endocrinology. 49(4)
Non-tumour causes of hyperprolactinaemia, including prolactin-elevating drugs, must be excluded. There is a general view that such drugs are unlikely to raise serum PRL above 3000 mU/I, but the literature is confusing. We report 8 patients receiving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb405c916e75ca6b034f713b45636f32
https://pubmed.ncbi.nlm.nih.gov/9876350
https://pubmed.ncbi.nlm.nih.gov/9876350
Publikováno v:
BMJ (Clinical research ed.). 313(7049)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5667080258db0b17f24334e1f7cb0ee8
https://pubmed.ncbi.nlm.nih.gov/8688762
https://pubmed.ncbi.nlm.nih.gov/8688762
Autor:
E. H. McLaren, Anne Pollock
Publikováno v:
Obstetrical & Gynecological Survey. 54:245-246
OBJECTIVE Non-tumour causes of hyperprolactinaemia, including prolactin-elevating drugs, must be excluded. There is a general view that such drugs are unlikely to raise serum PRL above 3000 mU/l, but the literature is confusing. We report 8 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8d1112b03c525b4e013be087afe2142
https://doi.org/10.1097/00006254-199904000-00018
https://doi.org/10.1097/00006254-199904000-00018
Publikováno v:
BMJ. 315:1463-1463
Editor—Skinner et al's suggestion that patients with symptoms of hypothyroidism and normal results of thyroid function tests might benefit from treatment with thyroxine1 received considerable publicity in our local evening newspaper. As a result, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113527a6c57ba8620eb92ee4c0a0447c
https://doi.org/10.1136/bmj.315.7120.1463
https://doi.org/10.1136/bmj.315.7120.1463
Publikováno v:
BMJ. 313:92-92
We report a case of a 66 year old man with maturity onset diabetes who developed a rapidly reversible increase in insulin requirement while receiving interferon alfa 2a for hepatitis C. The patient's diabetes had been well controlled for three years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f552be14ab0440d22b4b3c9b513bb1f9
https://doi.org/10.1136/bmj.313.7049.92a
https://doi.org/10.1136/bmj.313.7049.92a
Autor:
E H McLaren
Publikováno v:
BMJ. 301:1164-1164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a14939cd65196c2b704d0829b35c0d61
https://doi.org/10.1136/bmj.301.6761.1164
https://doi.org/10.1136/bmj.301.6761.1164